HTB South

10th International Workshop on Clinical Pharmacology of HIV Therapy, 15-17 April 2009, Amsterdam

Introduction

Reports from the workshop

The following reports from this meeting have been largely compiled from the abstracts of these studies.

It is disappointing that the abstracts from the virology-education meetings are not published online, and that only a selection of presentations from the meeting are available.
http://www.HIVpresentation.com

A useful summary report of the drug-interaction studies presented at the meeting is available on the Liverpool University website ( in the April 2009 news archive).
http://www.hiv-druginteractions.org/new/Content.asp?ID=431&TDM=

Reports in this issue are:

  • Interactions between ARVs and antimalarials atovaquone and proguanil
  • Efavirenz-related studies: genetics, smoking and TDM
  • Atazanavir: a suitable case for TDM?
  • A CYP2B6 haplotype influences nevirapine plasma concentrations following a single dose to reduce mother to child transmission
  • Population pharmacokinetic model of nevirapine maternal to infant transfer through breastfeeding
  • Phenotypic and genotypic inhibitory quotients and virologic response in treatment experienced children
  • Tenofovir pharmacokinetics in three tenofovir-containing regimens in children and adolescents
  • Bioavailability of Thai generic lopinavir/ritonavir

Links to other websites are current at date of posting but not maintained.